Watson 370 10 mg (Loxapine Succinate 10 mg)
Pill with imprint Watson 370 10 mg is White & Yellow, Capsule-shape and has been identified as Loxapine Succinate 10 mg. It is supplied by Watson Laboratories, Inc..
Loxapine is used in the treatment of agitated state; agitation; schizophrenia and belongs to the drug class miscellaneous antipsychotic agents. FDA has not classified the drug for risk during pregnancy. Loxapine 10 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Watson 370 10 mg
Loxapine Succinate
- Imprint:
- Watson 370 10 mg
- Strength:
- 10 mg
- Color:
- White & Yellow
- Size:
- 18.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antipsychotic agents
- Pregnancy Category:
- N - Not classified
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Watson Laboratories, Inc.
- Inactive Ingredients:
- lactose anhydrous
benzyl alcohol
butylparaben
edetate calcium disodium
gelatin
magnesium stearate
methylparaben
polacrilin potassium
propylparaben
sodium lauryl sulfate
sodium propionate
magnesium silicate
titanium dioxide
D&C Yellow No. 10
FD&C Yellow No. 6
Note: Inactive ingredients may vary.
Other Labelers / Repackagers:
| NDC Code | Labeler / Repackager |
|---|---|
| 51079-0901 | UDL Laboratories Inc. |
More about loxapine
- Loxapine Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- 6 Reviews
- Drug class: miscellaneous antipsychotic agents
Consumer resources
- Loxapine
- Loxapine inhalation
- Loxapine Capsules
- Loxapine Inhalation Powder
- Loxapine (Advanced Reading)
- Loxapine Inhalation (Advanced Reading)
Other brands: Loxitane, Adasuve
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
